GlassScriptPhysician profile
Malvika Arya
NPI 1659935096
$5,471.09
in general payments reported to CMS, 2019-2025
18 companies · $1,523 in 2025
The $1,523 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.09 · 2022: $479 · 2023: $2,181 · 2024: $1,265 · 2025: $1,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,169 · Consulting Fee: $1,100 · Grant: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,168.61 |
| Consulting Fee | $1,100.00 |
| Grant | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $1,800.00 | 2023-2025 | Eylea |
| Abbvie INC. | $637.16 | 2022-2025 | Ozurdex |
| Alcon Vision LLC | $507.78 | 2022-2024 | Hydrus Microstent, Centurion |
| Regeneron Healthcare Solutions, INC. | $494.30 | 2023-2024 | Eylea Hd, Eylea |
| Glaukos Corporation | $306.72 | 2024-2025 | Istent Infinite, Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Alimera Sciences, INC. | $248.12 | 2024 | Yutiq, Iluvien |
| Genentech USA, INC. | $234.50 | 2023-2024 | Vabysmo |
| Astellas Pharma US INC | $222.15 | 2023-2024 | Izervay |
| Coherus Oncology, INC. | $125.00 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $124.76 | 2025 | Xdemvy |
| Dompe US, INC. | $116.68 | 2025 | Oxervate |
| Sight Sciences, INC. | $114.11 | 2023-2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $107.46 | 2023 | Envista Mx60 Iol, Ic-8 Apthera Iol |
| Mallinckrodt Hospital Products INC. | $106.03 | 2025 | Acthar |
| Dutch Ophthalmic, USA | $104.85 | 2023 | Tissueblue, Eva, Combined Machine |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $101.40 | 2023 | Vabysmo |
| Ani Pharmaceuticals, INC. | $96.98 | 2025 | Purified Cortrophin Gel |
| Viiv Healthcare Company | $23.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malvika Arya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.